Gilead Sciences Financial Ratios
GILD / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
37.5%
ROE ranks in the top 25% among Health Care companies
Profit Margin
28.9%
Net Income / Revenue
Asset Turnover
0.50
Revenue / Total Assets
Equity Multiplier
2.60
Total Assets / Equity
Composite: 37.5% (reported: 37.5%)
Profitability
Liquidity
Current Ratio
1.55
Quick Ratio
1.40
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.50
Inventory Turnover
3.51
Days Sales Outstanding
61 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
-2.6%
+15.0pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.